Playlist


Gurbanguly Berdimuhamedov: If Everything Is Well in China, It Will Be Well in the Whole World
21 Mar. 12:05During an interview with China's "CGTN" channel, the Chairman of the Halk Maslakhaty of Turkmenistan, Gurbanguly Berdimuhamedov, shared his deep appreciation for the leadership of President Xi Jinping. The National Leader of the Turkmen people noted that they are bound by years of warm friendship, characterized by sincerity and mutual transparency. Through their collective efforts, the two nations have launched large-scale projects and united their capabilities to achieve regional stability and global sustainable development.
The National Leader characterized Xi Jinping as a world-class leader whose prestige stems from his firm protection of China's national interests and his responsible approach to critical international issues. He noted that under Xi’s leadership, China has achieved remarkable progress across all sectors and is successfully planning for the future. The results of the recent sessions of the National People's Congress were cited as a prime example of the country's steady advancement and strategic foresight.
A key point of the discussion was the Chairman's appraisal of the four global initiatives proposed by President Xi: the Global Security Initiative, the Global Civilization Initiative, the Global Development Initiative, and the Global Governance Initiative. Gurbanguly Berdimuhamedov stated that he views these initiatives as strategically vital conditions for the well-being of all humanity. These frameworks offer a new vision for international cooperation based on shared growth and security.
Concluding the interview, the Chairman of the Halk Maslakhaty emphasized China's decisive role in global equilibrium. "If everything is well in China, it will be well in the whole world," he remarked, underscoring the interconnectedness of global prosperity. Gurbanguly Berdimuhamedov wished President Xi Jinping robust health, family happiness, and continued success in his state duties, while wishing the people of China lasting prosperity. This statement reaffirms the high level of strategic partnership and personal rapport between the leaders of the two countries.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.